Erin Russell L.'s most recent trade in eHealth Inc was a trade of 34,574 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| eHealth Inc | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 34,574 | 115,037 (0%) | 0% | 0 | Common Stock | |
| Fortrea Holdings Inc | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 38,817 | 62,763 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 264 | 4,369 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 264 | 263 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 527 | 527 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 23,946 | 23,946 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2024 | 151 | 4,105 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin Russell L. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2024 | 151 | 0 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Sep 2024 | 152 | 151 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Sep 2024 | 152 | 3,954 (0%) | 0% | - | Common Stock | |
| eHealth Inc | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 31,760 | 80,463 (0%) | 0% | 0 | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 303 | 4,914 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 303 | 303 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Sale of securities on an exchange or to another person at price $ 279.24 per share. | 31 May 2024 | 1,112 | 3,802 (0%) | 0% | 279.2 | 310,520 | Common Stock |
| Kadant, Inc. | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 606 | 606 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | L. Erin Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2023 | 217 | 4,611 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin Russell L. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2023 | 217 | 0 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2023 | 217 | 217 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2023 | 217 | 4,394 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Sale of securities on an exchange or to another person at price $ 219.48 per share. | 13 Sep 2023 | 1,250 | 4,177 (0%) | 0% | 219.5 | 274,344 | Common Stock |
| eHealth Inc | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 24,446 | 48,703 (0%) | 0% | 0 | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 434 | 5,427 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 434 | 434 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 868 | 868 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 235 | 4,993 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 235 | 0 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2022 | 235 | 4,758 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2022 | 235 | 235 | - | - | Restricted Stock Unit | |
| eHealth Inc | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 16,560 | 24,257 (0%) | 0% | 0 | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 471 | 4,523 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 471 | 470 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 941 | 941 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 252 | 4,052 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 252 | 0 | - | - | Restricted Stock Unit | |
| eHealth Inc | Erin L. Russell | Director | Purchase of securities on an exchange or from another person at price $ 28.12 per share. | 12 Nov 2021 | 3,556 | 7,697 (0%) | 0% | 28.1 | 99,998 | Common Stock |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2021 | 252 | 252 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2021 | 252 | 3,800 (0%) | 0% | - | Common Stock | |
| eHealth Inc | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 3,374 | 4,141 (0%) | 0% | 0 | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 24 Jun 2021 | 450 | 3,548 (0%) | 0% | 180 | 81,000 | Common Stock |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 505 | 504 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 505 | 3,998 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 1,009 | 1,009 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Sale of securities on an exchange or to another person at price $ 171.96 per share. | 17 May 2021 | 249 | 3,694 (0%) | 0% | 172.0 | 42,818 | Common Stock |
| Kadant, Inc. | Erin L. Russell | Director | Sale of securities on an exchange or to another person at price $ 174.15 per share. | 17 May 2021 | 201 | 3,493 (0%) | 0% | 174.2 | 35,005 | Common Stock |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 521 | 3,943 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 521 | 0 | - | - | Restricted Stock Unit | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2020 | 521 | 3,422 (0%) | 0% | - | Common Stock | |
| Kadant, Inc. | Erin L. Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2020 | 521 | 521 | - | - | Restricted Stock Unit |